Is sotoraxibu available in China? Is it easy to buy?

Introduction: Sotorasibu is indicated for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with KRAS G12C mutations. Sotoraxib, formerly known as AMG 510, is designed to bind to KRAS G12C, locking the protein in an inactive state and preventing it from sending signals that drive uncontrolled cell growth. The drug's targeting approach does not affect unmutated KRAS proteins. Sotorasib is the world's first pharmaceutical KRAS G12C inhibitor after more than 40 years of research on KRAS mutated oncoproteins.

The listing status of sotoraxibu in China

has been listed in Taiwan, China, and Hong Kong, China, but as of May 11, 2024, it has not yet been listed in mainland China. Sotoracib was developed by Amgen and has received accelerated approval from the US FDA for the treatment of patients with locally advanced or metastatic non-small cell lung cancer carrying KRAS G12C mutations who have received at least one previous systemic therapy.

How to purchase Sotolazeb

Sotolazeb can be purchased from pharmacies or hospitals in Taiwan and Hong Kong, but it must meet the drug indications and be purchased with a prescription from a doctor. In addition, it can also be purchased through domestic medical service institutions. The selling price of sotoraxibu in China will vary, and patients are advised to learn more about the specific price.

The price of sotorasibu

The price of the German version of sotorasibu (Amg510) is about 43,980$-50,000$ per box, and the specification of a box is 120mg*240 pills. The price of the Bangladesh Everest version of sotorasibu (Amg510) is about 4,000$, and the specification of a box is 120mgx56 pills. Different versions of Sotoraxibu also have different prices.

Factors affecting the price of sotoraxib

1. Research and development costs: Developing new drugs requires huge investments, including the efforts of scientific researchers, the cost of clinical trials and the cost of drug production. These costs are often reflected in the price of the drug.

2. Market demand: If sotoracib has significant efficacy in treating specific lung cancer and patients have high demand for it, suppliers may set corresponding prices based on market conditions.

3. Exchange rate changes: For imported drugs, exchange rate fluctuations may also affect their pricing in different countries.

Drug prices may change over time, and as the market develops, competition increases, and new treatment options become available, the price of sotorasib may adjust.